Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: ICAP at Columbia University
Street 1: 722 West 168 St
Street 2: MSPH Box 18
City: New York
Province: NY
Post Code: 10032
Country: United States of America
Phone: 212-342-0505
Organization Email:
Web Site:
Other Online Presence:

Focal Point Contact Information

Salutation: Dr
First Name: Andrea
Last Name: Howard
Title: Director, Clinical & Training Unit
Phone: 212-305-0385

Alternate Focal Point Contact Information

Salutation: Dr
First Name: Bereket
Last Name: Alemayehu
Title: Associate Director, Laboratory Services
Phone: 212-304-5506

General Information

Board Constituency: Technical agencies
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Academic / Research Institution
Organization Type - Secondary: None
Organization Description:
ICAP was founded in 2003 at Columbia University’s Mailman School of Public Health. Now a global leader in HIV/AIDS and health systems strengthening, ICAP provides technical assistance and implementation support to governments and non-governmental organizations in more than 20 countries. ICAP is recognized for its collaborative approach to strengthening health systems at the national, regional, district, and facility levels, including assistance with strategic planning, development of policies and guidelines, workforce development, training and mentorship, and monitoring and evaluation. ICAP faculty and staff expertise encompasses: the optimization of HIV prevention, care, and treatment programs; the integration of HIV and TB services; the effective design of laboratory, monitoring evaluation and health information systems; leveraging HIV programs to enhance services for maternal and child health and chronic non-communicable diseases; and task-shifting, task-sharing, and the use of lay health workers.
ICAP has supported work at more than 1,200 health facilities across 21 countries around the world. More than 1.5 million people have received HIV services through ICAP-supported programs.
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Research and Development
Technical Assistance

Other Organization Information

Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 100 +
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Network with other partners
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
Our TB work is international

Geographical Reach

Which country is your headquarters located in: United States of America
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Cote d'Ivoire
Democratic Republic of the Congo
South Africa
South Sudan
United Republic of Tanzania
United States of America


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

• Serving as lead member on TB/HIV technical working groups in several countries and working hand-in-hand with Ministries of Health, ICAP has supported the creation of national TB/HIV guidelines and the development of indicators for building national tools for monitoring the quality of HIV and TB care
• Facilitating and conducting TB/HIV integration technical assistance meetings, trainings, and on-site mentoring and supportive supervision for Ministry of Health and facility staff
• Establishing “one-stop” integrated TB/HIV services
• Providing technical assistance to Ministries of Health in the development of national TB/HIV clinical support tools, job aids, and training curricula, including national TB screening questionnaires and diagnostic algorithms
• Supporting the establishment of a Pediatric TB/HIV Center of Excellence in Tanzania to train health cadres in the skills they need to provide a comprehensive package of services for TB/HIV co-infected children
• Supporting the establishment of an international accredited TB/HIV training center in South Africa that will educate and train postgraduate health workers on TB/HIV, infection control, and key elements of operational research
• Supporting scale up of isoniazid preventive therapy for people living with HIV in Ethiopia and Lesotho
• Working with provincial and regional health bureaus, district health teams, and health facility teams to build capacity in TB/HIV integration, and to ensure child- and family-friendly health services
• Providing technical assistance on the implementation of patient adherence and empowerment strategies characterized by the active involvement of community organizations and people living with HIV
• Instituting provider-initiated counseling and testing at TB clinics
• Supporting programs that engage hard-to-reach populations, such as people who inject drugs in Tanzania and Central Asia, fishermen and their families from Lake Victoria in Tanzania, pastoralists in Ethiopia and migrant miners in Lesotho
• Supporting the development, implementation, and monitoring of facility-specific infection control plans
• Disseminating lessons learned, models, and best practices to multidisciplinary teams and sites implementing TB/HIV programs through workshops, South-to-South exchange, and print material
• Developing TB/HIV and TB infection control job aids, some of which have been adapted as national tools

Laboratory Strengthening:
• Providing technical assistance to laboratories to appropriately equip them for various assays; to introduce LED microscopy; to develop algorithms to incorporate the use of Xpert MTB/RIF for rapid diagnosis of TB and rifampicin resistance; and to improve workflow, specimen transfer using motorcycles, record keeping, and supply chain management
• Supporting the rehabilitation and renovation of laboratories, with a particular focus on TB infection control
• Providing technical assistance in proper specimen collection procedures to improve diagnostic yield, including sputum induction and gastric aspirate

• Conducting a cluster-randomized trial to evaluate the effectiveness, cost-effectiveness, and acceptability of a combination intervention package to improve early ART initiation, retention, and TB treatment success among HIV-infected TB patients in Lesotho (START Study)
• Conducting a cluster-randomized trial to evaluate the effectiveness of a combination intervention package for isoniazid preventive therapy provision in HIV programs in Ethiopia (ENRICH Study)
• Evaluating the effectiveness of innovative interventions to increase TB case finding and successful treatment among miners and their families in Lesotho


Declaration of interests:
No conflicts of interest were delacred.

Application date: February 11, 2014
Last updated: March 11, 2014